SCHEMBL31268824

SCHEMBL31268824

CNC(=O)COc1ccc(-c2nc3c(OC4(C)CC4)ncnc3n2Cc2cc(C)ccn2)c(Cl)c1

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PIK3CD O00329 2/20 0.34
▸ NPC1 O15118 1/20 0.32
▸ RAB9A P51151 1/20 0.32
▸ CETP P11597 1/20 0.31
▸ PDK2 Q15119 1/20 0.31
▸ PKM P14618 1/20 0.31
▸ ALDH1A1 P00352 1/20 0.31
▸ LMNA P02545 1/20 0.31
▸ TP53 P04637 1/20 0.31
▸ MAPT P10636 1/20 0.31
▸ TSHR P16473 1/20 0.31
▸ PRKAB2 O43741 1/20 0.31
▸ PRKAG1 P54619 1/20 0.31
▸ PRKAA2 P54646 1/20 0.31
▸ PRKAA1 Q13131 1/20 0.31
▸ PRKAG3 Q9UGI9 1/20 0.31
▸ PRKAG2 Q9UGJ0 1/20 0.31
▸ PRKAB1 Q9Y478 1/20 0.31
▸ KCNH2 Q12809 1/20 0.30
▸ SCN5A Q14524 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31269346 0.94 PIK3CD (0.34) PIK3CDPDK2PKMPRKAB2PRKAG1
SCHEMBL31268974 0.92 ALDH1A1 (0.35) PIK3CDNPC1RAB9ACETPALDH1A1
SCHEMBL31268819 0.92 PIK3CD (0.36) PIK3CDKCNH2SCN5ASCN9A
SCHEMBL31268804 0.92 PIK3CD (0.37) PIK3CDRAB9ALMNA
SCHEMBL31269166 0.92 ALDH1A1 (0.40) PIK3CDNPC1RAB9APDK2ALDH1A1
SCHEMBL31269460 0.91 PIK3CD (0.34) PIK3CDNPC1RAB9A
SCHEMBL31268898 0.91 PIK3CD (0.33) PIK3CDNPC1RAB9ACETPALDH1A1
SCHEMBL31268842 0.91 PIK3CD (0.33) PIK3CDNPC1RAB9A
SCHEMBL31268837 0.90 KDM4E (0.33) PIK3CDNPC1RAB9ACETPALDH1A1
SCHEMBL31269100 0.90 PIK3CD (0.34) PIK3CDPDK2ALDH1A1TP53KCNH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4689155-A1 USE OF INHIBITORS TO INCREASE EFFICIENCY OF CRISPR/CAS INSERTIONS Astrazeneca AB (SE) 2026-02-11 — — EP disclosed
WO-2024201368-A1 USE OF INHIBITORS TO INCREASE EFFICIENCY OF CRISPR/CAS INSERTIONS ASTRAZENECA AB (SE) 2024-10-03 — — WO disclosed
Send feedback